BPC-157 10mg — HPLC
Pureza 99.734%Manufacturer batch report. HPLC purity 99.734% (spec >98%); measured content 10.21 mg against a 10 mg label; identity confirmed as BPC-157. Nexus Scientific task #100545.
Debes tener 21 años o más para acceder a este sitio.
Debes confirmar tu edad y aceptar los términos para entrar.
Informes de laboratorio independiente de nuestros lotes. Encuentre el producto, compare el número de lote del vial y abra el PDF original.
Manufacturer batch report. HPLC purity 99.734% (spec >98%); measured content 10.21 mg against a 10 mg label; identity confirmed as BPC-157. Nexus Scientific task #100545.
FTIR identification confirms CJC-1295 and Ipamorelin. HPLC purity 99.8% (spec ≥98%); HPLC potency CJC-1295 5.1 mg + Ipamorelin 5.7 mg (10.8 mg total for the 10 mg blend). Report COA261804-003, issued 10/8/2026.
FTIR identification confirms GHK-Cu. HPLC purity 99.8% (spec ≥98%); HPLC potency 48.2 mg (96.4% of the 50 mg label). Report COA261804-002, issued 10/8/2026.
Manufacturer batch report. HPLC purity 99.737% (spec >98%); measured content 101.37 mg against a 100 mg label; identity confirmed as GHK-Cu. Nexus Scientific task #100580.
FTIR identification confirms the Glow blend. HPLC purity 99.7% (spec ≥98%); HPLC potency GHK-Cu 56.3 mg, BPC-157 5.8 mg, TB-500 9.1 mg (71.2 mg total for the 70 mg blend). Report COA261804-004, issued 10/8/2026.
HPLC-UV/MS. Chromatographic purity >99.9%; measured content 19.6 mg (97.9% of the 20 mg label claim); identity confirmed by mass spectral match. Lab #204779, report issued 5/8/2026.
Manufacturer batch report. HPLC purity 99.102% (spec >98%); measured content 30.44 mg against a 30 mg label; identity confirmed. Nexus Scientific task #100524.
HPLC-UV/MS. Chromatographic purity >99.9%; measured content 9.80 mg (98.0% of the 10 mg label claim); identity confirmed by mass spectral match. Lab #204778, report issued 5/8/2026.
Manufacturer batch report, one HPLC page per component of the blend (spec >98% each): GHK-Cu 50.19 mg / 99.663%, TB-500 10.25 mg / 99.845%, KPV 10.15 mg / 99.662%, BPC-157 10.15 mg / 99.398%. Components analyzed 5/18/2026 (GHK-Cu page dated 6/14/2026). Nexus Scientific tasks #100554–#100557.
HPLC-UV/MS. Chromatographic purity 99.1%; measured content 10.8 mg (107.9% of the 10 mg label claim); identity confirmed by mass spectral match. Lab #207096, report issued 6/22/2026.
FTIR identification confirms NAD. HPLC purity 99.7% (spec ≥98%); HPLC potency 716.6 mg (143.3% of the 500 mg label). Report COA261804-001, issued 10/8/2026.
Manufacturer batch report. HPLC purity 99.939% (spec >98%); measured content 10.69 mg against a 10 mg label; identity confirmed as PT-141. Nexus Scientific task #100593.
Manufacturer batch report. HPLC purity 99.226% (spec >98%); measured content 5.41 mg against a 5 mg label; identity confirmed as Selank. Nexus Scientific task #100567.
Manufacturer batch report. HPLC purity 99.771% (spec >98%); measured content 30.15 mg against a 30 mg label; identity confirmed as Semaglutide. Nexus Scientific task #100530.
Manufacturer batch report. HPLC purity 99.356% (spec >98%); measured content 5.42 mg against a 5 mg label; identity confirmed as Semax. Nexus Scientific task #100563.
Manufacturer batch report. HPLC purity 99.692% (spec >98%); measured content 10.51 mg against a 10 mg label; identity confirmed as SS-31. Nexus Scientific task #100585.
Manufacturer batch report. HPLC purity 99.902% (spec >98%); measured content 10.23 mg against a 10 mg label; identity confirmed as TB-500. Nexus Scientific task #100544.
Ningún informe coincide con la búsqueda.
Cada certificado corresponde al lote analizado. Compare el número de lote del informe con el impreso en su vial. Solo para uso en investigación.